Try a new search

Format these results:

Searched for:

person:levinz01

in-biosketch:yes

Total Results:

12


Preparing program directors to address unprofessional behavior

Chapter by: Caligor, Eve; Levin, Ze'ev; Deringer, Emily
in: Remediation in medical education : a mid-course correction by Kalet, Adina; Chou, Calvin L [Eds]
New York : Springer, [2014]
pp. 285-296
ISBN: 1461490251
CID: 1019762

Personality disorders

Chapter by: Caligor, Eve; Yeomans, Frank; Levin, Ze'ev
in: Psychiatry by Cutler, Janis L [Eds]
New York : Oxford University Press, 2014
pp. 257-290
ISBN: 019932607x
CID: 1745892

Psychiatric assessment of aggressive patients: a violent attack on a resident [Case Report]

Antonius, Daniel; Fuchs, Lara; Herbert, Farah; Kwon, Joe; Fried, Joanna L; Burton, Paul R S; Straka, Tara; Levin, Ze'ev; Caligor, Eve; Malaspina, Dolores
Aggressive patients often target psychiatrists and psychiatric residents, yet most clinicians are insufficiently trained in violence risk assessment and management. Consequently, many clinicians are reluctant to diagnose and treat aggressive and assaultive features in psychiatric patients and instead focus attention on other axis I mental disorders with proven pharmacological treatment in the hope that this approach will reduce the aggressive behavior. Unclear or nonexistent reporting policies or feelings of self-blame may impede clinicians from reporting assaults, thus limiting our knowledge of the impact of, and best response to, aggression in psychiatric patients. The authors pre-sent the case of a young adult inpatient with a long history of antisocial and assaultive behavior who struck and injured a psychiatric resident. With this case in mind, the authors discuss the diagnostic complexities related to violent patients, the importance of assessing violence risk when initially evaluating a patient, and the relevance of risk assessment for treatment considerations and future management. This report illustrates common deficiencies in the prevention of violence on inpatient psychiatric units and in the reporting and response to an assault, and has implications for residency and clinician training
PMID: 20194488
ISSN: 0002-953x
CID: 107929

Kapuran rinsho seishin igaku kyu ando e rebyu = Kaplan and Sadock's study guide and self-examination review in psychiatry

Sadock, Benjamin J; Sadock, Virginia A; Levin, Ze'ev; Toru, Michio; Iwawaki, Atsushi; Watanabe, Akihiko
Tokyo : Medikarusaiensuintanashonaru, 2009
Extent: 596 p. ; 26 cm.
ISBN: 9784895926140
CID: 1975

Personality disorders

Chapter by: Levin, Ze'ev
in: Psychiatry clerkship guide by Manley, Myrl RS [Eds]
Philadelphia PA : Mosby/Elsevier, 2007
pp. 283-294
ISBN: 1416031324
CID: 5583

Kaplan and Sadock's study guide and self-examination reveiw in psychiatry

Sadock, Benjamin J; Sadock, Virginia A; Levin, Ze'ev
Philadelphia : Wolters Kluwer Health / Lippincott Williams & Wilkins, 2007
Extent: ix, 468 p. : ill. ; 27 cm
ISBN: 0781780438
CID: 1400

Special events in the residency program

Chapter by: Levin, Ze'ev; Bernstein, Carol A
in: Handbook of psychiatric education by Kay, Jerald; Silberman, Edward K; Pessar, Linda F [Eds]
Washington, DC, US: American Psychiatric Publishing, Inc., 2005
pp. 289-313
ISBN: 1585621897
CID: 3829

The patient's day on the inpatient unit

Chapter by: Pandya, Anand; Levin, Ze'ev
in: Psychiatry clerkship guide by Manley, Myrl RS [Eds]
St.Louis MO : Mosby, 2003
pp. 3-13
ISBN: 0323016405
CID: 5595

The medical student's role on the inpatient service

Chapter by: Pandya, anand; Levin, Ze'ev
in: Psychiatry clerkship guide by Manley, Myrl RS [Eds]
St.Louis MO : Mosby, 2003
pp. 14-24
ISBN: 0323016405
CID: 5596

Phase II studies of the glycine antagonist GV150526 in acute stroke - The North American experience [Meeting Abstract]

Babikian, V; Licata-Gehr, E; Joseph, LN; Bailey, P; Boyle, R; MacDougall, A; MacLean, G; Wheelock, WB; Kolyvas, G; Banas, T; Wissman, MA; Heckaman, JD; Porter, MA; Bhat, MH; Later, PE; Wissmann, SD; Ottinger, CJ; Stevens, JC; Plant, R; Chang, FL; Beatty, J; Beatty, TW; Cohen, SB; Vasquez, AB; Schmidt, DW; Allen, T; Bellavance, A; Hebert, L; Berger, L; Filatrault, R; Nasredding, Z; Trottier, AG; Duplessis, M; Maison, FG; Ninkovic, S; Berman, B; Yipelkonen, M; Miskin, BM; Shaivitz, SA; Benavente, O; Bruce, G; Solomen, D; Sherman, D; Hart, R; Kanter-Carolin, M; Lalonde, DR; Rogers, D; Bruce, G; Leonard, A; Brott, T; Spilker, J; Broderick, J; Kothari, R; Panicoli, A; Sauerbeck, L; Miller, R; Clark, WM; Deely, SM; Fisher, S; Lutsep, H; Quinn, J; Crawford, J; Egan, R; Nesbit, G; Al-Azzaz, A; Earley, C; Herr, M; Michel, H; Dike, G; Maragakis, N; Polydefkis, M; Wagner, K; Wang, M; Rusa, R; Jones, C; Kerr, D; Moo, L; Pardo, C; Silverman, I; Hoffman, J; Diebert, E; Jinnah, H; York, J; Hoke, A; Vega-Bermudez, F; Comi, A; Hillis, A; Rich, J; Ervin, J; Bryan, C; Allen, AA; Kelley, GB; Perll, MF; Box, MS; Robles, LH; Zwibelman, JS; Hopewell, DK; Ryan, ME; Wendland, RT; Feinberg, W; Coull, B; Rose-Taylor, D; Ahern, G; Anderson, LR; Keim, S; Sherman, S; Rose-Taylor, D; Haley, EC; Morris, A; Ahern, K; Johnston, K; Solenski, N; Nathan, B; Bleck, T; Worrall, B; Leszczyszyn, D; Hemstreet, M; Kiely, J; Burns, T; Klein, C; Cail, W; Huff, S; Quinn, J; Armstrong, R; Provencio, J; Snider, R; Van Gerpen, J; Hsu, C; Duke, L; Banet, G; Choi, J; Lee, JM; Lowenkopf, T; Innes, G; Metcalf, C; Huang, P; Rumball, C; Miller, B; Haegert, J; Holmes, A; Oldring, B; MacNab, J; Grosch, R; Deady, B; Street, R; O'Brien, R; Vertesi, L; Erhardt, G; Finkler, J; Tessler, C; Glazer, S; Noseworthy, R; Knazen, M; MacDonald, P; Smyth, A; Karp, J; Phillips, B; Spiegel, A; Bowman, SC; Hampsey, JP; Habib, MW; Schroeder, T; Stopnytsky, K; Kertecz, A; Piotrowski, S; Cooper, P; Lyden, P; Rapp, K; Jackson, C; Ellis, R; Noack, H; Sabbagh, M; Galasko, D; Rapp, K; Kelly, N; Werner, J; Chang, CL; Morris, DT; Pusek, S; Hinn, A; Ma, J; Bernard, E; Phillips, S; Reidy, Y; Gubitz, G; Tanha, F; Leckey, R; Ansell, J; Darvesh, S; Aguilar, E; Pullicino, P; Starr, S; Munschauer, FE; Ross, DB; Norris, D; Steinberg, J; Zaret, B; Maniar, M; Sacco, RL; Boden-Albala, B; Jimenez, M; Mohr, JP; Kargman, D; Marshall, R; Elkind, MS; Roberts, K; Gan, R; Shipley, N; Aboumatar, S; Greene, R; Shuaib, A; Kadribasic, E; Keegan, M; Stewart, B; Khaan, K; Shuaib, A; Dean, TR; Richardson, P; Moussavian, M; Faloriji, W; Johnson, M; Levin, Z; Silliman, S; Fuqua, PS; Berger, A; Najjar, S; Schwartz, R; Solomon, DH; Limon, L; Hart, RG; Sherman, DG; Carolin, MCK; Lalonde, DR; Benavente, O; Starkman, S; Schubert, GB; Dobkin, B; Saver, J; Vespa, P; Alger, J; Teitelbaum, J; Lachance, N; Robillard, A; Lachapelle, J; Boileau, J; Rousseau, S; Roy, L; Laplante, P; Thurston, S; McGee, JR; Lutz, MA; McGee, FE; Harris, JK; White, RJ; O'Bannon, JM; Brush, JJ; Cohen, RJ; Smith, TA; Mathe, SA; Karner, SF; Worthington, AK; Deel, JG; Tong, D; Hock, N; Albers, G; O'Brien, M; Woofenden, A; Yenari, M; Freyberg, S; Guro, G; Hock, N; Tuhrim, S; Augustine, S; Weinberger, J; Horowitz, D; Sheinart, K; Schonewille, W; Atlas, S; Veloso, F; Reid, M; Adaikari, K; Gebhardt, V; Nair, CPV; Wang, D; Vrabel, D; McLean, J; Kumar, J; Garwacki, D; Roda, M; Hui, E; Coyner, J; Vrabel, D; Honings, D; Rose, J; Sladana, R; Wechsler, L; Yasko, L; Knepper, L; Massaro, L; Graham, S; Larkin, G; Ulicny, T; Yonas, H; Barch, C; Lin, H; Brader, E; Berkey, K; Ludovici, J; Kaufmann, A; De Cesare, S; Hodgdon, A; MacLeod, B; Thompson, D; Piatkowski, S; O'Toole, K; Yasko, L; Ilkhanipour, K; Maenza, R; Mathias, S; Thulborn, K; Jungreis, C; Cockley, P; Corsello, G; Ammon, C; Rasheed, A; Weston, L; Bourque, G; Silverberg, D; Harper, B; Robinson, D; MacEachern, M; Williams, AD; Roth, R; Rice, M; Hogan, J; Pellegrino, TR; Holland, MT; Lanoue, RJ; Redding, A; Handler, J; Haley, EC; Alves, WM; Elder, L; Davenport, K; McClure, K; Knowlton, S; Cuccia, E; Maupin, K; Lotts, M; Hund, M; Shelleck, K; Szewc, T; Cail, W; Wagner, G; Gates, K; Earley, C; Haley, EC; Johnston, KC; Sacco, RL; Schuaib, A; Snipes, R; Wang, DZ; Brass, LM; Clark, WR; Grotta, JC; Harrison, M; McIntyre, N; Zimmerman, H; Wellcome, G; Snipes, R; Watson, D; Ordronneau, P; Hoke, F; Ko, WJ; Clayton, L; EnneyO' Mara, L; Johnson, J; Orander, C; Card, B; Green, S; N Amer GAIN Investigators
Background and Purpose-GV150526, a selective glycine site antagonist, reduces infarct volume in rats with focal cerebral ischemia. Safety and efficacy in humans with acute stroke are being investigated, We sought to further explore the safety. pharmacokinetics, and preliminary outcome of GV150526 treatment in patients with a clinical diagnosis of acute stroke. Methods-Two trials were conducted in North America. The North American Glycine Antagonist in Neuroprotection trial (GAIN 1) (GLYA2001; United States only) was designed as a sequential dose escalation study. GAIN 2 (GLYA2005; United States and Canada) was designed to further assess the safety of the highest dose tolerated in GAIN 1. Both trials were randomized (2:1), double-blind, and placebo controlled, Treatment was started within 12 hours of symptom onset; patients with both ischemic stroke and primary intracerebral hemorrhage were included in both trials. Results-The dose escalation study (GAIN 1) completed 3 dosing tiers. Enrollment was suspended before escalation to the fourth tier because of laboratory reports of transiently elevated bilirubin levels in a concurrent European study that employed the dose targeted for this tier. After review by an independent safety committee of the worldwide safety data, the second study (GAIN 2) commenced. One hundred nine patients were randomized and dosed with study drug, either an 800-mg loading dose followed by 200 mg every 12 hours for 3 days of GV150526 or placebo. The incidence of serious adverse events was similar in the drug and placebo groups. Mild irritation at the infusion site and symptoms suggestive of mild and reversible altered mentation were reported more frequently in the GV150526 group than in the placebo group. Hyperbilirubinemia was reported in 6% of GV150526-treated patients compared with 3% of placebo-treated patients. Outcome at 4 weeks after stroke was better in GV150526-treated patients, but the studies were not powered to show statistical significance, and the baseline neurological deficits in the GV150526-treated patients were less severe. Conclusions-These preliminary studies suggest that GV150526 is well tolerated by patients with suspected acute stroke. Further pivotal studies testing the efficacy and safety of GV150526 in acute stroke are ongoing.
ISI:000085039900003
ISSN: 0039-2499
CID: 2739162